BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 4:56:00 PM | Browse: 1043 | Download: 788
Publication Name World Journal of Respirology
Manuscript ID 4329
Country United States
Received
2013-06-27 11:47
Peer-Review Started
2013-06-27 17:25
To Make the First Decision
2013-07-05 18:35
Return for Revision
2013-07-08 16:46
Revised
2013-07-09 04:17
Second Decision
2013-07-18 14:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-07-19 01:12
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-11-26 13:27
Publish the Manuscript Online
2013-12-03 15:44
ISSN 2218-6255 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Respiratory System
Manuscript Type Review
Article Title Von Hippel-Lindau protein and respiratory diseases
Manuscript Source Invited Manuscript
All Author List Tianji Chen, Miranda Sun and Guofei Zhou
Funding Agency and Grant Number
Funding Agency Grant Number
Pulmonary Hypertension Association and American Lung Association to Dr. Guofei Zhou
Corresponding Author Guofei Zhou, PhD, Department of Pediatrics, University of Illinois at Chicago, University of Illinois Hospital and Health Sciences System, 840 S. Wood Street, M/C 856, Ste 1206, Chicago, IL 60612, United States. guofei@uic.edu
Key Words Von Hippel-Lindau protein; Lung cancer; Pulmonary fibrosis; Pulmonary hypertension
Core Tip Although von Hippel-Lindau protein (pVHL) was first identified as a tumor suppressor and is best known as a component of ubiquitin protein ligase for the proteasomal degradation of hypoxia inducible factor (HIF)-?, recent studies suggest that pVHL contributes to many lung diseases in both HIF-dependent and HIF-independent pathways. Loss of pVHL promotes pulmonary arterial hypertension via activation of HIF. In lung cancer, loss of pVHL promotes epithelial-mesenchymal transition and cancer migration and invasion while decreasing cell proliferation and colonization. pVHL also induces fibronectin/integrin ?5?1/focal adhesion kinase signaling to facilitate fibrogenesis. pVHL mediates Na-K-ATPase degradation to cause decreased edema clearance during hypoxia.
Publish Date 2013-12-03 15:44
Citation Chen T, Sun M, Zhou G. Von Hippel-Lindau protein and respiratory diseases. World J Respirol 2013; 3(3): 48-56
URL http://www.wjgnet.com/2218-6255/full/v3/i3/48.htm
DOI http://dx.doi.org/10.5320/wjr.v3.i3.48
Full Article (PDF) WJR-3-48.pdf
Manuscript File 4329-Review.doc
Answering Reviewers 4329-Answering reviewers.pdf
Copyright License Agreement 4329-Copyright assignment.pdf
Peer-review Report 4329-Peer review(s).pdf
Scientific Editor Work List 4329-Scientific editor work list.doc